DJT vs CLOV

For growth investors, Clover Health Investments, Corp.

(CLOV) is the stronger pick with 40. 3% revenue growth year-over-year, versus -12. 4% for Trump Media & Technology Group Corp. (DJT). Analysts rate Clover Health Investments, Corp. (CLOV) a "Hold" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Clover Health Investments, Corp.

(CLOV) delivered a total return of -67. 4%, compared to -82. 0% for Trump Media & Technology Group Corp. (DJT). Over 10 years, the gap is even starker: CLOV returned -73. 7% versus DJT's -82. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Clover Health Investments, Corp.

(CLOV) is the lower-risk stock at 1. 22β versus Trump Media & Technology Group Corp. 's 1. 93β — meaning DJT is approximately 58% more volatile than CLOV relative to the S&P 500.

By revenue growth (latest reported year), Clover Health Investments, Corp.

(CLOV) is pulling ahead at 40. 3% versus -12. 4% for Trump Media & Technology Group Corp. (DJT). On earnings-per-share growth, the picture is similar: Clover Health Investments, Corp. grew EPS -93. 6% year-over-year, compared to -448. 8% for Trump Media & Technology Group Corp.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Clover Health Investments, Corp.

(CLOV) is the more profitable company, earning -4. 4% net margin versus -110. 8% for Trump Media & Technology Group Corp. — meaning it keeps -4. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CLOV leads at -4. 4% versus -51. 4% for DJT. At the gross margin level — before operating expenses — DJT leads at 82. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Clover Health Investments, Corp.

(CLOV) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 22)). Trump Media & Technology Group Corp. (DJT) carries a higher beta of 1. 93 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CLOV: -73. 7%, DJT: -82. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (DJT (Communication Services) and CLOV (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: DJT is a small-cap quality compounder stock; CLOV is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.